Agustín Zavala
Affiliations: | 2015-2018 | Université Paris-Saclay, Gif-sur-Yvette, Île-de-France, France |
Google:
"Agustín Zavala"Mean distance: (not calculated yet)
Parents
Sign in to add mentorBogdan Iorga | grad student | 2015-2018 | Université Paris-Saclay | |
(Structure-function studies of beta-lactamases) | ||||
Thierry Naas | grad student | 2015-2018 | Université Paris-Saclay | |
(Structure-function studies of beta-lactamases) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Dabos L, Raczynska JE, Bogaerts P, et al. (2023) Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 Variant. Antimicrobial Agents and Chemotherapy. e0109522 |
Romero E, Oueslati S, Benchekroun M, et al. (2021) Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D). European Journal of Medicinal Chemistry. 219: 113418 |
Dabos L, Zavala A, Bonnin RA, et al. (2020) Substrate Specificity of OXA-48 after β5-β6 Loop Replacement. Acs Infectious Diseases. 6: 1032-1043 |
Oueslati S, Iorga BI, Tlili L, et al. (2019) Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity. The Journal of Antimicrobial Chemotherapy. 74: 2239-2246 |
Zavala A, Retailleau P, Elisée E, et al. (2019) Genetic, Biochemical, and Structural Characterization of CMY-136 β-Lactamase, a Peculiar CMY-2 Variant. Acs Infectious Diseases. 5: 528-538 |
Dabos L, Zavala A, Bonnin RA, et al. (2019) Crystal Structure of Rationally Designed OXA-48loop18 beta-lactamase Acs Infectious Diseases |
Dabos L, Jousset AB, Bonnin RA, et al. (2018) Genetic and Biochemical Characterization of OXA-535, a Distantly Related OXA-48-Like β-Lactamase. Antimicrobial Agents and Chemotherapy. 62 |
Dabos L, Bogaerts P, Bonnin RA, et al. (2018) Genetic and Biochemical characterization of OXA-519, a novel OXA-48-like β-lactamase. Antimicrobial Agents and Chemotherapy |
Selwa E, Elisée E, Zavala A, et al. (2018) Blinded evaluation of farnesoid X receptor (FXR) ligands binding using molecular docking and free energy calculations. Journal of Computer-Aided Molecular Design. 32: 273-286 |
Naas T, Oueslati S, Bonnin RA, et al. (2017) Beta-lactamase database (BLDB) - structure and function. Journal of Enzyme Inhibition and Medicinal Chemistry. 32: 917-919 |